
Novavax Vaccine Is Spearheaded by Institutional Investors
As the Novavax COVID-19 vaccine enters the U.S. market, the people behind the company are coming into question. Who owns Novavax?
The latest news in the healthcare sector including biotech and telehealth.



















































© Copyright 2026 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.